Successful Brincidofovir Treatment of Metagenomics-detected Adenovirus Infection in a Severely Ill Signal Transducer and Activator of Transcription-1-deficient Patient

Pediatr Infect Dis J. 2019 Mar;38(3):297-299. doi: 10.1097/INF.0000000000002090.

Abstract

A signal transducer and activator of transcription-1-deficient patient presented with prolonged fever, cachexia, anemia, hypoalbuminemia and finally relapsing debilitating mycobacterial osteomyelitis while receiving a previously effective antimycobacterial treatment. Progression despite rigorous workup and multiple antibiotics prompted shotgun metagenomics revealing adenovirus in liver samples. Brincidofovir led to a complete, sustained clinical recovery, including osteomyelitis, probably attributed to reversal of adenovirus-induced immune dysregulation.

Publication types

  • Case Reports

MeSH terms

  • Adenoviridae Infections / diagnosis*
  • Adenoviridae Infections / drug therapy*
  • Adenoviridae Infections / immunology
  • Antiviral Agents / therapeutic use*
  • Cytosine / analogs & derivatives*
  • Cytosine / therapeutic use
  • Humans
  • Immunocompromised Host
  • Liver / immunology
  • Liver / virology
  • Male
  • Metagenomics
  • Organophosphonates / therapeutic use*
  • Osteomyelitis / drug therapy
  • Osteomyelitis / microbiology
  • STAT1 Transcription Factor / deficiency*
  • Treatment Outcome
  • Young Adult

Substances

  • Antiviral Agents
  • Organophosphonates
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • brincidofovir
  • Cytosine